ProfileGDS4718 / 205124_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 41% 46% 46% 42% 32% 40% 42% 40% 41% 37% 43% 38% 41% 36% 41% 32% 43% 36% 34% 50% 38% 39% 42% 38% 40% 40% 34% 36% 45% 40% 40% 47% 38% 38% 34% 39% 50% 51% 43% 38% 35% 39% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.087842
GSM549102patient 115, normal, homogenized [OPG study]5.0406341
GSM549104patient 119, normal, homogenized [OPG study]5.2785746
GSM549108patient 138, normal, homogenized [OPG study]5.3598746
GSM549119patient 077, normal, homogenized [OPG study]5.1105242
GSM549133patient 032, cancer, homogenized [OPG study]4.5713732
GSM549139patient 042, cancer, homogenized [OPG study]4.9518940
GSM549099patient 107, normal, homogenized [OPG study]5.1092642
GSM549109patient 139, normal, homogenized [OPG study]5.0256340
GSM549110patient 046, normal, homogenized [OPG study]5.0458741
GSM549114patient 063, normal, homogenized [OPG study]4.7970437
GSM549122patient 082, normal, homogenized [OPG study]5.1300943
GSM549134patient 033, cancer, homogenized [OPG study]4.90438
GSM549136patient 036, cancer, homogenized [OPG study]4.9638441
GSM549140patient 044, cancer, homogenized [OPG study]4.7742836
GSM549111patient 047, normal, homogenized [OPG study]5.0330241
GSM549113patient 057, normal, homogenized [OPG study]4.5541832
GSM549132patient 031, cancer, homogenized [OPG study]5.1246143
GSM549137patient 038, cancer, homogenized [OPG study]4.8027536
GSM549142patient 047, cancer, homogenized [OPG study]4.8320534
GSM549100patient 110, normal, homogenized [OPG study]5.5150850
GSM549107patient 135, normal, homogenized [OPG study]4.8737538
GSM549115patient 068, normal, homogenized [OPG study]4.9026139
GSM549116patient 072, normal, homogenized [OPG study]5.0600242
GSM549120patient 078, normal, homogenized [OPG study]4.8854438
GSM549131patient 030, cancer, homogenized [OPG study]4.9544140
GSM549118patient 074, normal, homogenized [OPG study]4.990840
GSM549129patient 027, cancer, homogenized [OPG study]4.7255134
GSM549123patient 088, normal, homogenized [OPG study]4.7801236
GSM549124patient 006, cancer, homogenized [OPG study]5.3027945
GSM549126patient 015, cancer, homogenized [OPG study]5.0104840
GSM549128patient 025, cancer, homogenized [OPG study]4.967740
GSM549103patient 117, normal, homogenized [OPG study]5.3988647
GSM549117patient 073, normal, homogenized [OPG study]4.8657438
GSM549138patient 041, cancer, homogenized [OPG study]4.8929338
GSM549141patient 045, cancer, homogenized [OPG study]4.6564234
GSM549130patient 028, cancer, homogenized [OPG study]4.9281939
GSM549101patient 111, normal, homogenized [OPG study]5.5278350
GSM549105patient 128, normal, homogenized [OPG study]5.5980751
GSM549106patient 134, normal, homogenized [OPG study]5.1041843
GSM549112patient 048, normal, homogenized [OPG study]4.8746238
GSM549125patient 011, cancer, homogenized [OPG study]4.7883135
GSM549127patient 024, cancer, homogenized [OPG study]4.935639
GSM549135patient 035, cancer, homogenized [OPG study]4.6903335